SPR secures $37M for pain relief implant 

Cleveland-based medical device company SPR Therapeutics raised $37 million in series D funding for its peripheral nerve stimulation system, the company said Oct. 18 in a news release.

Advertisement

The system involves one or two thin leads implanted under the skin, which deliver pulses of electricity to the nerves to block or reduce pain signals. 

The FDA recently approved the 60-day device for a broader range of applications, including treatment in the head, neck and front of the torso, SPR said in an Oct. 19 news release.

Advertisement

Next Up in Spinal Tech

  • Zavation Medical has acquired ChoiceSpine, and Derek Kuyper will be CEO of the combined company, according to a Feb. 26…

  • Carlsmed saw significant gains in fourth-quarter and 2025 revenue, according to financial results posted Feb. 25. Five things to know:…

Advertisement

Comments are closed.